Read + Share
Amedeo Smart
Independent Medical Education
Harris E. Oral Empagliflozin Receives FDA Approval for Children With Diabetes. JAMA 2023 Jul 5. doi: 10.1001/jama.2023.12057.PMID: 37405747
Email
LinkedIn
Facebook
Twitter
Privacy Policy